Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedAug 23, 2025
DataAggregated Company Financials
Companies9
- 7D0.1%
- 3M6.4%
- 1Y3.2%
- YTD-3.6%
The Biotech is pretty flat in the last 7 days, but Hester Biosciences has stood out, gaining 6.2%. In line with that, the industry has also been flat over the past 12 months. Looking forward, earnings are forecast to grow by 51% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 23 Aug 2025 | ₹528.0b | ₹169.4b | ₹4.6b | 63.5x | 114x | 3.1x |
| Mon, 21 Jul 2025 | ₹581.3b | ₹163.7b | ₹10.6b | 56.2x | 54.7x | 3.6x |
| Wed, 18 Jun 2025 | ₹471.6b | ₹163.8b | ₹10.6b | 49x | 44.4x | 2.9x |
| Fri, 16 May 2025 | ₹461.2b | ₹175.9b | ₹10.6b | 55.7x | 43.5x | 2.6x |
| Sun, 13 Apr 2025 | ₹427.3b | ₹158.8b | ₹8.5b | 47.1x | 50.1x | 2.7x |
| Tue, 11 Mar 2025 | ₹434.4b | ₹158.9b | ₹8.4b | 48.8x | 52x | 2.7x |
| Thu, 06 Feb 2025 | ₹515.0b | ₹158.3b | ₹8.2b | 58.1x | 62.4x | 3.3x |
| Sat, 04 Jan 2025 | ₹498.0b | ₹159.6b | ₹14.5b | 64x | 34.3x | 3.1x |
| Mon, 02 Dec 2024 | ₹495.4b | ₹159.6b | ₹14.5b | 39.1x | 34.1x | 3.1x |
| Wed, 30 Oct 2024 | ₹438.2b | ₹157.8b | ₹15.7b | 44.6x | 27.8x | 2.8x |
| Fri, 27 Sep 2024 | ₹495.0b | ₹157.7b | ₹15.7b | 32.5x | 31.5x | 3.1x |
| Sun, 25 Aug 2024 | ₹463.2b | ₹157.7b | ₹15.7b | 30.1x | 29.5x | 2.9x |
| Tue, 23 Jul 2024 | ₹440.6b | ₹157.4b | ₹10.4b | 49.2x | 42.5x | 2.8x |
| Thu, 20 Jun 2024 | ₹429.8b | ₹157.4b | ₹10.4b | 44.8x | 41.5x | 2.7x |
| Sat, 18 May 2024 | ₹395.9b | ₹165.6b | ₹10.2b | 46.5x | 38.8x | 2.4x |
| Mon, 15 Apr 2024 | ₹357.1b | ₹155.4b | ₹12.0b | 36.9x | 29.7x | 2.3x |
| Wed, 13 Mar 2024 | ₹349.8b | ₹155.4b | ₹12.0b | 33.5x | 29.1x | 2.3x |
| Fri, 09 Feb 2024 | ₹370.7b | ₹144.9b | ₹5.2b | 66.7x | 71.2x | 2.6x |
| Sun, 07 Jan 2024 | ₹381.3b | ₹145.0b | ₹5.3b | 60.7x | 72.6x | 2.6x |
| Tue, 05 Dec 2023 | ₹318.0b | ₹145.0b | ₹5.3b | 53.7x | 60.5x | 2.2x |
| Thu, 02 Nov 2023 | ₹291.2b | ₹133.6b | ₹4.7b | 42.5x | 61.6x | 2.2x |
| Sat, 30 Sep 2023 | ₹355.5b | ₹133.8b | ₹4.8b | 30.6x | 74.4x | 2.7x |
| Mon, 28 Aug 2023 | ₹435.7b | ₹142.3b | ₹7.2b | 35.3x | 60.7x | 3.1x |
| Wed, 26 Jul 2023 | ₹321.3b | ₹120.4b | ₹4.5b | 41.9x | 71.3x | 2.7x |
| Fri, 23 Jun 2023 | ₹320.4b | ₹120.4b | ₹4.5b | 40.9x | 71.1x | 2.7x |
| Sun, 21 May 2023 | ₹319.0b | ₹106.8b | ₹16.2b | 27.5x | 19.7x | 3x |
| Tue, 18 Apr 2023 | ₹298.7b | ₹106.6b | ₹16.4b | 14.8x | 18.3x | 2.8x |
| Thu, 16 Mar 2023 | ₹293.2b | ₹106.5b | ₹16.3b | 30.5x | 18x | 2.8x |
| Sat, 11 Feb 2023 | ₹321.0b | ₹99.2b | ₹17.9b | 30.8x | 17.9x | 3.2x |
| Mon, 09 Jan 2023 | ₹340.9b | ₹99.2b | ₹18.0b | 33x | 19x | 3.4x |
| Wed, 07 Dec 2022 | ₹361.0b | ₹99.2b | ₹18.0b | 35.6x | 20.1x | 3.6x |
| Fri, 04 Nov 2022 | ₹356.2b | ₹95.5b | ₹18.2b | 31.2x | 19.6x | 3.7x |
| Sun, 02 Oct 2022 | ₹382.1b | ₹95.5b | ₹18.1b | 32.5x | 21.1x | 4x |
| Tue, 30 Aug 2022 | ₹399.0b | ₹95.5b | ₹18.1b | 33.5x | 22x | 4.2x |
Price to Earnings Ratio
22x
Current Industry PE
- Investors are optimistic on the Indian Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 114x which is higher than its 3-year average PE of 42.2x.
- The industry is trading close to its 3-year average PS ratio of 2.9x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 37% per year over the last three years.
- Meanwhile revenues for these companies have grown 21% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 1.84% | |
| Healthcare | 0.80% | |
| Biotech | 0.13% | |
| Biotech | 0.13% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 524669 Hester Biosciences | ₹2.02k | 6.2% +₹998.7m | -18.5% | PE45.7x | |
| BIOCON Biocon | ₹359.50 | 0.07% +₹333.6m | 2.2% | PE124.6x | |
| 514336 Genesis IBRC India | ₹38.04 | 10.2% +₹45.9m | 151.9% | PE14.2x | |
| 524663 Bharat Immunologicals & Biologicals | ₹22.63 | 2.4% +₹23.3m | -25.1% | n/a | |
| 532039 Zenotech Laboratories | ₹55.30 | 0.6% +₹19.5m | -18.2% | PE63.5x |